Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?

インフレ率を考慮し、加重平均で見れば、米国におけるジェネリック医薬品全体の約 17% は急速な価格上昇の傾向 https://t.co/p8mm3bUoXY

後発医薬品の価格動向はインフレ率で調整しなければ、その適正値を論じることはできませんね。 Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average ... https://t.co/p8mm3bUoXY

@Z3RO_Y34R "over 90% of all drugs sold in the US are generics. Recently, there have been examples of large price increases in the generic market." https://t.co/gUKe5Gc9xr

@Z3RO_Y34R Also... "over 90% of all drugs sold in the US are generics. Recently, there have been examples of large price increases in the generic market." https://t.co/gUKe5Gc9xr